ALINESS ProbioBalance PSYCHOBIOTIC Bifizen 6.5 billion PROBIOTIC

Food supplement

Ingredients

1 capsule

2 capsules (daily portion)

Prebiotic - Fibregum Bio LAW polysaccharide

(aw<0,2%)

100 mg

200 mg

Plantain - extract (Plantago Lanceolata)

20 mg

40 mg

MICROENCAPSULATED PROBIOTIC BIFIZEN BLEND:

6,5*109 cells

13*109 CELLS

Lactobacillus rhamnosus GG (ATCC 53103)

2,5*109 cells

5*109 cells

Limosilactobacillus yeast LF16 (DSM 26956)

1*109 cells

2*109 cells

Lacticaseibacillus rhamnosus LR06 (DSM 21981)

1*109 cells

2*109 cells

Lactiplantibacillus plantarum LP01 (LMG P-21021)

1*109 cells

2*109 cells

Bifidobacterium longum 04 (DSM 23233)

1*109 cells

2*109 cells

(1*109 cells =1 billion)

Ingredients: Prebiotic - Fibregum Bio LAW polysaccharide (aw<0.2%), Ribwort plantain - extract (Plantago Lanceolata),MICROENCAPSULATED PROBIOTIC BIFIZEN BLEND: Lactobacillus rhamnosus GG ATCC 53103, Limosilactobacillus fermentum LF16 (DSM 26956), Lacticaseibacillus rhamnosus LR06 (DSM 21981), Lactiplantibacillus plantarum LP01 (LMG P-21021), Bifidobacterium longum 04 (DSM 23233), bacterial shell: glycerol esters of fatty acids, capsule shell: binder - hydroxypropylmethylcellulose.

Recommended daily dose: 1-2 capsules daily with a meal.

Do not exceed the recommended daily dose. A food supplement should not be used as a substitute for a varied diet. A balanced diet and a healthy lifestyle are the basis for the proper functioning of the body.

ProbioBalance Psychobiotic contains 6.5 billion bacteria in each capsule in the patented and tested BIFIZEN composition. Each bacterium has been covered with a double lipid layer, providing an effective barrier and allowing the bacteria to safely pass through the acidic environment of the stomach to reach the intestines intact, where it is to demonstrate its biological activity.

Storage conditions: Store at room temperature out of the reach of children. Protect from moisture.

Temperatures above 25 C should be avoided.

In order to ensure the highest quality of the product throughout its expiration date, 20% technological allowance is added at the production stage, i.e. approximately 20% more bacteria to each capsule.

The use of microencapsulated lactic acid bacteria requires a specific, patented analysis method, available from the manufacturer, to quantify viable bacterial cells (flow cytometry). Patent No. RM2009A000591

Manufacturer: Medicaline

Packaging: 30 capsules